| http://www.w3.org/ns/prov#value | - This transaction strengthens Santen's lineup of glaucoma products, significantly expands Santen's footprint in Japan, Asia and Europe, and is an important step in achieving its long term corporate vision to become ???A Specialized Pharmaceutical Company with a Global Presence??? by 2020.
|
